Project Details
Projekt Print View

Modulation intrinsischer Immunität durch adenovirale Onkoproteine

Subject Area Virology
Cell Biology
Term from 2013 to 2017
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 234760463
 
Final Report Year 2018

Final Report Abstract

The human adenovirus type 5 (HAdV5) early regulatory proteins E1B-55K and E4orf6 are multifunctional regulators of HAdV replication and cell transformation that control several processes, including modulation of p53-induced apoptosis and growth arrest, selective late viral mRNA transport and shut-off of host cell protein synthesis. Their lytic and oncogenic properties largely correlate with their ability to interact with and to manipulate a number of cellular key regulators controlling transcription, apoptosis and DNA repair (e.g. p53, Mre11, DNA ligase IV and BLM). In addition, data from our group indicated that the multifunctional properties of the viral proteins are regulated interactions with components of the phosphorylation, ubiquitin- and SUMO-conjugation machineries in the context of PML Nuclear Bodies (PML-NBs). On the basis of these findings it was the aim of this study to analyze the interactions of E1B-55K and E4orf6 with PML isoforms and other PML-NB components and to investigate the functional consequences of these interactions on viral protein functions, cell transformation and HAdV replication. Our data show that E1B-55K and E4orf6 promote viral and cell growth through interactions with (i) cellular factors involved in reprogramming/remodeling of the host chromatin (HOXB7, SPOC1, ATRX, KAP1/TRIM28/TIF-1G), (ii) components of the ubiquitin- and SUMO-conjugation machineries (USP7, UBC9), and (iii) the PML-NB components PML, Sp100 and Daxx. These multiprotein complexes have been implicated in diverse cellular processes such as transcriptional regulation, DNA repair, tumor suppression, and ultimately, they have been defined as important host restriction factors involved in antiviral defense. In parallel, we discovered unique enzymatic-like functions of E1B-55K, which correlate with its growth-promoting and oncogenic activities. We show that E1B-55K can stimulate, in addition to p53, the SUMOylation of Sp100 and, likely, other still unknown target proteins. Besides, our studies indicate a STUbL-like activity for E1B-55K as the viral protein can interact with the SUMO-targeted Ubiquitin-ligase (STUbL) RNF4, promoting Daxx degradation. These results introduce completely new functions for a viral oncoprotein and suggest that this posttranslational activity is an important key to how the HAdV protein promotes viral and cell growth. Altogether these data clearly illustrate the importance of PML-NBs and associated factors in virus growth restriction and suggest that HAdV oncoproteins antagonize the intrinsic antiviral activities of PML-NBs and other tumor suppressors to enable efficient viral replication in a temporally coordinated manner. In addition, these observations establish an exciting link between Ubiquitin, SUMOylation, PML-NBs and viral oncogenesis.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung